When is a PSA test for prostate cancer really worth it?

The PSA test for the early detection of prostate cancer is controversial.

The Institute for Quality and Efficiency in Health Care has re-evaluated well-known studies and states that screening for the early detection of prostate cancer leads to overdiagnosis and overtreatment.

This causes unnecessary suffering.

Professor Hartwig Huland from the Hamburg Martini Clinic explains who can benefit from a PSA test and who cannot.